These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19494793)

  • 1. In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age.
    Allegaert K; Vanhaesebrouck S; Verbesselt R; van den Anker JN
    Ther Drug Monit; 2009 Aug; 31(4):411-5. PubMed ID: 19494793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
    Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
    Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of variability in clearance of exogenous compounds in neonates.
    Allegaert K; Van Den Anker JN; Tayman C; De Hoon J
    Verh K Acad Geneeskd Belg; 2009; 71(3):141-64. PubMed ID: 20088252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study.
    Linakis MW; Cook SF; Kumar SS; Liu X; Wilkins DG; Gaedigk R; Gaedigk A; Sherwin CMT; van den Anker JN
    Clin Pharmacokinet; 2018 Oct; 57(10):1325-1336. PubMed ID: 29654492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life.
    Allegaert K; Verbesselt R; Rayyan M; Debeer A; de Hoon J
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):251-6. PubMed ID: 17609736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates.
    Allegaert K; de Hoon J; Verbesselt R; Vanhole C; Devlieger H; Tibboel D
    Acta Paediatr; 2005 Sep; 94(9):1273-9. PubMed ID: 16278989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both postnatal and postmenstrual age contribute to the interindividual variability in tramadol glucuronidation in neonates.
    Allegaert K; Vanhole C; Vermeersch S; Rayyan M; Verbesselt R; de Hoon J
    Early Hum Dev; 2008 May; 84(5):325-30. PubMed ID: 17913403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
    Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of UDP-glucuronosyltransferase (UGT2B15) and glucuronidation of paracetamol in healthy population.
    Mehboob H; Iqbal T; Jamil A; Khaliq T
    Pak J Pharm Sci; 2016 May; 29(3 Suppl):1037-41. PubMed ID: 27383482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
    Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases.
    Bachrich T; Thalhammer T; Jäger W; Haslmayer P; Alihodzic B; Bakos S; Hitchman E; Senderowicz AM; Penner E
    Hepatology; 2001 May; 33(5):1053-9. PubMed ID: 11343231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE.
    Tankanitlert J; Morales NP; Howard TA; Fucharoen P; Ware RE; Fucharoen S; Chantharaksri U
    Pharmacology; 2007; 79(2):97-103. PubMed ID: 17164591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is indirect hyperbilirubinemia a useful biomarker of reduced propofol clearance in neonates?
    Smits A; De Cock RF; Cossey V; Knibbe CA; Allegaert K
    Biomark Med; 2012 Jun; 6(3):283-9. PubMed ID: 22731901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.